Polyclonal antithymocyte immunoglobulin

This page covers all Polyclonal antithymocyte immunoglobulin drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Human thymocytes and T lymphocyte surface antigens (CD2, CD3, CD4, CD8, HLA-DR).

Targets

Human thymocytes and T lymphocyte surface antigens (CD2, CD3, CD4, CD8, HLA-DR)

Marketed (1)

• Anti-Human Thymocyte Immunoglobulin, Rabbit · Peking Union Medical College Hospital · Immunology
  This rabbit-derived polyclonal antibody depletes T lymphocytes by binding to antigens on human thymocytes and T cells, thereby suppressing the immune response.

Patent intelligence

• polyclonal antithymocyte immunoglobulin patent landscape — aggregated cliff calendar, attackable patents, originator estates